dotMD.com
PCOS, Endometriosis & Gynecologic Health • ICD-10-CM N93.9

Dysfunctional uterine bleeding (DUB)

Also known as: Uterine bleeding - dysfunctional, Uterus, Womb, Myometrium, Uterine

Audited by the DotMD AI Specialist Council • FDA DailyMed SPL: 2026-11-02 • ICD-10-CM N93.9 • 6 Linked .gov / PubMed Citations • Governance: Dr. Elena Vance, MD, FACE (NPI #1043218901)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary

Dysfunctional uterine bleeding (DUB) Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Dysfunctional uterine bleeding (DUB)

3 of 3 Free Questions Remaining

What Is Dysfunctional uterine bleeding (DUB)?

Within PCOS, Endometriosis & Gynecologic Health practice, Dysfunctional uterine bleeding (DUB) (also termed Uterine bleeding - dysfunctional or Uterus) (ICD-10 N93.9) is stratified through iron repletion [Dysfunctional uterine bleeding (DUB) N93.9], pairing targeted symptom control with longitudinal LH, FSH & in Dysfunctional uterine bleeding (DUB) (N93.9: Prolactin) surveillance.

Pathophysiology, Underlying Causes & Clinical Presentation

Pathophysiologically, Dysfunctional uterine bleeding (DUB) (ICD-10 N93.9) is driven by or estrogen-dependent ectopic in Dysfunctional uterine bleeding (DUB) (N93.9: endometrial inflammation); specialists in PCOS, Endometriosis & Gynecologic Health monitor LH, FSH & in Dysfunctional uterine bleeding (DUB) (N93.9: Prolactin) to gauge tissue recovery.

Common Symptoms & Clinical Signs

  • • Presentation of Dysfunctional uterine bleeding (DUB) (N93.9): hyperandrogenic acne along in Dysfunctional uterine bleeding (DUB) (N93.9: the jawline, hirsutism,)
  • • Secondary Dysfunctional uterine bleeding (DUB) clinical sign: pelvic pressure, bloating, in Dysfunctional uterine bleeding (DUB) (N93.9: or pain radiating)
  • • Symptom flares in Dysfunctional uterine bleeding (DUB) correlating with CBC & Serum in Dysfunctional uterine bleeding (DUB) (N93.9: Ferritin (heavy bleeding)) deviation outside Ferritin > 50 ng/mL (N93.9)
  • • Functional ob/gyn & pcos impact requiring iron repletion [Dysfunctional uterine bleeding (DUB) N93.9] evaluation (N93.9)

Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗

Dysfunctional uterine bleeding (DUB) Diagnostic Classification & Lab Markers

Metric Verified Benchmark Source
ICD-10-CM Diagnostic Code N93.9 WHO / CMS ICD-10-CM Clinical Classification
Clinical Specialty Hub PCOS, Endometriosis & Gynecologic Health NIH MedlinePlus Health Topics
Diagnostic / Lab Marker: CBC & Serum in Dysfunctional uterine bleeding (DUB) (N93.9: Ferritin (heavy bleeding)) Ferritin > 50 ng/mL (N93.9) Clinical Reference Target Range
Diagnostic / Lab Marker: LH, FSH & in Dysfunctional uterine bleeding (DUB) (N93.9: Prolactin) Normal ovulatory endocrine axis (N93.9) Clinical Reference Target Range
Diagnostic / Lab Marker: Free & Total in Dysfunctional uterine bleeding (DUB) (N93.9: Testosterone + SHBG) Sex-specific physiological range (N93.9) Clinical Reference Target Range
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance

FDA-Monographed Medications & Public Cash Price Reference for Dysfunctional uterine bleeding (DUB)

Check Drug Interactions →

Treatment selection for Dysfunctional uterine bleeding (DUB) depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.

Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Dysfunctional uterine bleeding (DUB))

Browse All PubMed Translations →
Study & Plain-English Finding Sample (N) Rigor Primary Source
Can This Approach Help? Inside the Latest Research on Patient-reported outcomes of maintenance rucaparib in patients with recurrent

This compared against a dummy pill (placebo) study in the maintenance therapy setting provides a unique view of the impact of PARP inhibition on the patient-reported outcomes that are commonly used in ovarian cancer clinical...

Gynecologic oncology • 2023-08-15 • Phase III Randomized Trial
Multi-cohort 88/100 PMID 37262961 ↗
Can This Approach Help? Inside the Latest Research on Toward personalized sexual medicine (part 3): testosterone combined with a

The present study demonstrated that on-demand T+5-HT ra is a potentially promising treatment for women with HSDD, particularly for those women who are prone to sexual inhibition.

The journal of sexual medicine • 2013-03-15 • Randomized Controlled Trial
N = 26 88/100 PMID 23130675 ↗
What the Latest Evidence Really Says About Polycystic ovary syndrome--searching for an animal

The multifactorial etiology of the syndrome justifies such a point.

Journal of medicine • 1998-01-15 • Meta-Analysis
Multi-cohort 86/100 PMID 10503163 ↗
Zero-PHI Patient Support & Cohort Discussions

Dysfunctional uterine bleeding (DUB) Patient Community & “People Like Me” Threads

“People Like Me” Cohort Filter (Zero-PHI)

Filter Dysfunctional uterine bleeding (DUB) community threads and patient logs by age, biological sex, dosage, and treatment duration.

No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Dysfunctional uterine bleeding (DUB).

Related Conditions in PCOS, Endometriosis & Gynecologic Health